BEAT Therapeutics

🙋🏻♀️ Portugal em destaque no Prémio Europeu para Mulheres Inovadoras Duas empreendedoras portuguesas estão entre as vencedoras do Prémio Europeu para Mulheres Inovadoras, promovido pelo European Innovation Council (EIC). Ângela Carvalho, CEO da BEAT Therapeutics, e Mara G. Freire, CEO da RYA Purification Technologies, destacaram-se pelo impacto das suas inovações.   O prémio destaca o papel das mulheres na inovação e encoraja futuras gerações a liderarem projetos de ciência, tecnologia e empreendedorismo.   👉 Saiba mais sobre este reconhecimento: https://lnkd.in/d-JtuEpR #ANI #Inovação #WomenTechEU

Counting down to #BIOEurope! Reach out if you want to know more about BEAT Therapeutics latest advancements on our first-in-class DDR inhibitor as a targeted cancer therapy. Looking forward to (re)connecting with partners, colleagues, and diving into the latest biotech developments.

Yesterday, Blip.pt proudly hosted the Porto Tech Meetup - Portuguese Women in Tech | Women Take the Lead, celebrating the achievements of women in the tech industry. Our very own Senior Product Delivery Manager, Rita Viana Pinto, was part of the session, sharing her inspiring career journey, highlighting her evolution from technical roles to leadership. Rita also shared her experiences navigating strategic challenges and the transformative power of mentorship. 💡 Moderated by Inês Santos Silva, PWIT co-founder, the round table also counted on Maria João Souto (Angel Investor), Ângela Carvalho (CEO @ BEAT Therapeutics) and Teresa Carreiro (Co-Founder at Critical Manufacturing). #Blip #Flutter #WomenInTech #PortoTechMeetup #Leadership #CareerGrowth

New Talent at BEAT Therapeutics ✨ We are excited to announce three new students joining us, bringing a wealth of talent to our team! Inês Mota has been awarded an FCT scholarship to join us at BEAT Therapeutics. She is pursuing her doctorate in Pharmaceutical Sciences at the Faculty of Pharmacy, University of Porto (FFUP). Her research interests are focused on Molecular Biology, Oncobiology, and Cancer Pharmacology. With a BSc in Biology and an MSc in Cell and Molecular Biology, she gained valuable experience through internships at i3S and the IPO Porto Research Center (CI-IPOP). Combining her passion for research with a desire to improve people's lives, she is highly motivated to push the boundaries of knowledge in cancer research, seeking innovative solutions to combat this disease. Maria Miguel Pinto Lima is a second-year Oncology Master's student at Instituto de Ciências Biomédicas Abel Salazar (ICBAS) of the University of Porto, with a particular interest in cancer biology and pharmacology. Maria holds a degree in Biomedical Sciences from the University of Liverpool, UK, and has gained valuable skills through both her academic studies and an internship at i3S. Maria is highly curious and dedicated, with a strong ambition to drive cancer research forward, applying her skills and passion to make impactful contributions to the field. Luis Garcez is a Master's student in Biotechnology with a Bachelor's degree in Biochemistry from the University of Minho. His strong passion for exploring scientific principles and understanding complex biological systems drives his academic curiosity and motivation. Through his work at BEAT Therapeutics, Luís is eager to apply his knowledge and skills to contribute to advancing cancer research. Welcome aboard, Inês, Maria, and Luis! We look forward to the amazing work you will do with us at BEAT Therapeutics 🚀

Recently, we shared the incredible news that we are one of the 40 winners of the Women TechEU Call #1, selected out of 820 applications! 🎉🚀 👉🏼https://lnkd.in/d-9SM999 The first cohort program has officially kicked off, and we’re thrilled to be part of such an inspiring group of innovators and changemakers. If you are an EU-based, women-led business in deep tech, this is your chance! The application for the second cohort is still open, but hurry—applications close tomorrow! 🔗 https://lnkd.in/eHUYbcpA Don’t miss out on the chance to accelerate your business with tailored support, a €75K equity-free grant, and the opportunity to join an incredible community of women leaders in technology! #WomenTechEU #DeepTech #Biotech #WomenInTech #BEATTherapeutics

🌍🧬 Today is #WorldCancerResearchDay, a moment to reflect on the incredible strides being made in the fight against cancer. Cancer affects millions of lives each year, and research is the key to creating new treatments, improving diagnosis and survival rates, and ultimately BEATing cancer. It’s through research, innovation, collaboration, and dedication that we will achieve a healthier future. 👩🔬🔬 As part of the global effort, at BEAT Therapeutics, we are committed to advancing oncology research and developing innovative therapeutics to transform the landscape of cancer treatment. We believe that through science, we can rewrite the story of cancer. To all the researchers, healthcare professionals, and advocates tirelessly working in the fight against cancer - thank you for your dedication and commitment to making a difference! 🎗️

We’ve been holding onto some wonderful news ✨ BEAT Therapeutics and our CEO Ângela Carvalho are among the 40 winners for the first call of Women TechEU! As part of the initiative, we will receive a €75k grant but also 6 months of tailored services to work towards scaling up and be ready for our next challenge. The first cohort of winners shaping the future of the deep-tech ecosystem can be found here: https://lnkd.in/d-9SM999 Let’s start this journey! 🚀 #WomenTechEU #WomenInTech #Deeptech #Biotech #BEATTherapeutics

These days I am in beautiful Copenhagen attending TechBBQ ! I'm looking forward to connecting with fellow innovators, partners and discussing BEAT Therapeutics work towards advancing cancer therapies and improving cancer patients outcomes. If you’re attending, drop me a message—I’d love to chat! Oh, and we may have some news soon! 🚀

As we welcome the summer season, it's a time to celebrate accomplishments and look forward to new beginnings. We are thrilled to congratulate Pedro Dinis and Tomás Pinheiro on successfully obtaining their MSc in Molecular Bioengineering 🎓 Throughout their time with us, they have shown exceptional dedication, creativity, and passion for their work. We are proud to have been a part of their academic journey and look forward to seeing where their careers take them next 🚀 Congratulations, Pedro and Tomás! 👏

Last week, we travelled to Coimbra to attend Bluepharma Innovation Award | University of Coimbra ceremony. 🏅 We had the honor of accepting the award on behalf of BEAT Therapeutics, as part of a project led by Lucília Saraiva at the Faculdade de Farmácia da Universidade do Porto, and our CSO. We also seized this opportunity to gather the whole team and organize BEAT Therapeutics first annual meeting! 🎇 Thank you to Bluepharma for the award and for their continuous support of health innovation and research. #Innovationaward #Bluepharma #prémioinovação #BEATTherapeutics #oncologyinnovation